You are here: Industry Insights > price

News List

Converting Naloxone to OTC Expected to Increase Sales drugs
February 27, 2019
The demand for naloxone is relatively inelastic with respect to changes in its out-of-pocket price, and conversion to an over-the-counter medication is expected to increase naloxone pharmacy sales.....
Catalyst sparks price row in US with $300,000 rare disease drug pharmaphorum
February 13, 2019
The controversy over rising drug prices in the US has been reignited after it emerged that the yearly cost of the life-sustaining rare disease drug Firdapse has been hiked from free to more than $300,000.
Regeneron and Sanofi cut US list price of Praluent pharmaceutical-technology
February 13, 2019
Regeneron and Sanofi have announced they have lowered the list price of high cholesterol drug Praluent (alirocumab) in the US by approximately 60%....
Committee demands answers on rising cost of insulin in the US europeanpharmaceuticalreview
February 02, 2019
Letters have been sent to Eli Lilly, Novo Nordisk and Sanofi asking them to explain the rapidly increasing cost of insulin…
Test run of drug prices in ads exposes a loophole—and pharma's already using it fiercepharma
January 31, 2019
It’s no surprise that listing the high price of a drug in advertising would discourage consumers.
Insulin Price More Than Doubled in the United States drugs
January 24, 2019
Some Americans with type 1 diabetes have cut back on their insulin usage as the cost of the drug nearly doubled over a five-year period.....
Novartis migraine drug not cost effective: UK price watchdog expressbpd
January 14, 2019
Novartis, which pledged to work with NICE to address outstanding questions, said patients would lack new treatment options if the decision remains unchanged
Rising drug prices linked to older products, study finds europeanpharmaceuticalreview
January 09, 2019
The rising costs of brand-name drugs is largely driven by inflation in the prices of widely used existing drugs, according to a study published in the January issue of Health Affairs…
NEJM article, ANA challenge sticker prices in drug ads fiercepharma
December 05, 2018
In the latest salvos challenging the value of adding drug prices to pharma TV ads, two academics and a well-known advertising association have set out their arguments against the proposal.
Amgen cuts price of cholesterol drug Repatha by 60% pharmaceutical-technology
October 29, 2018
Amgen has announced plans to reduce the price of its cholesterol drug Repatha by 60% to $5,850 per year, in an effort to improve affordability through lowering patient copays.

Previous page 1 2 3 4 5 Next page